Clinical Trial Update: Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. [Phase 1]

View source ↗

Summary

A Phase 1 single-dose study in patients with COPD-associated pulmonary hypertension has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary, Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2014-02-28